Pfizer to submit breast cancer drug
May 18, 2014Research and Development, Sales and Marketing Pfizer, breast cancer, femara, palbociclib
Pfizer, currently in the middle of trying to acquire AstraZeneca for $106 billion, says it will soon submit its new …
Merck sells Colorado biologics plant to KBI
May 18, 2014Manufacturing and Production KBI, Merck, manufacturing
Merck & Co has swung the axe over its M&P operations again – this time for its biologics plant in …
Clinical evidence revisited
May 18, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials
One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …
Heartbreak for Novartis as FDA rejects drug
May 18, 2014Research and Development, Sales and Marketing GSK, Novartis, heart drug
Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …
AstraZeneca signs UK research deal
May 16, 2014Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer
The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …
Roche gets oncology boost with cancer vaccine
May 16, 2014Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology
Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …
Giotrif increases lung cancer survival
May 16, 2014Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer
Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …
AstraZeneca lung cancer data reveals promise
May 15, 2014Sales and Marketing ASCO, AstraZeneca, NSCLC, azd0291, lung cancer
AstraZeneca has released promising data in a lung cancer trial with one of its investigational drugs, AZD9291, which has breakthrough …
Scrap ‘iniquitous and outdated’ NHS prescription charges
May 15, 2014Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription
The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …
K-V Pharmaceutical hires head of women’s healthcare
May 15, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KV, paul williams
K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division. Williams …
MedImmune signs Incyte oncology deal
May 15, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology
MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …
Pfizer: ‘fewer scientists’ after merger
May 14, 2014Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover
Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …
More late-stage anguish for GSK heart drug
May 14, 2014Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart
GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …
GSK China head arrested over bribery charges
May 14, 2014Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly
A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …
Pfizer grilled by MPs – but AZ revelations shock
May 14, 2014Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover
The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …
Just:: appoints digital specialist
May 14, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Prideaux, Just, Just::, digital
Just:: Health Communications has hired Daniel Prideaux to head-up its digital offering. Prideaux joins from DigitasLBi and previously worked at …
NICE: no early Zytiga use
May 14, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate
Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …
Toshiba creates disease diagnosis tool
May 13, 2014Medical Communications, Research and Development, Sales and Marketing Disease, Japan, breath analyser, toshiba
Japan’s multinational electronics firm Toshiba has developed a breath-analysing prototype system that it says can be used to diagnose diseases. …
Teva considers up to 27 plant closures
May 13, 2014Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics
Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
